DrugPatentWatch Database Preview
Litigation Details for Teva Pharmaceuticals USA Inc. v. Sandoz Inc. (D. Del. 2014)
Email this page to a colleague
» See Plans and PricingTeva Pharmaceuticals USA Inc. v. Sandoz Inc. (D. Del. 2014)
| Docket | Start Trial | Date Filed | 2014-09-10 |
| Court | District Court, D. Delaware | Date Terminated | 2017-01-31 |
| Cause | 35:271 Patent Infringement | Assigned To | Colm Felix Connolly |
| Jury Demand | Defendant | Referred To | |
| Parties | AMNEAL PHARMACEUTICALS COMPANY GMBH; AMNEAL PHARMACEUTICALS LLC; DR REDDY'S LABORATORIES INC.; DR REDDY'S LABORATORIES LTD; MOMENTA PHARMACEUTICALS INC.; MYLAN INC.; MYLAN PHARMACEUTICALS INC.; NATCO PHARMA LTD.; PFIZER INC.; SANDOZ INC.; SYNTHON B.V.; SYNTHON PHARMACEUTICALS INC.; SYNTHON S.R.O. BLANSKO; TEVA NEUROSCIENCE INC; TEVA PHARMACEUTICAL INDUSTRIES LTD; TEVA PHARMACEUTICALS USA INC.; YEDA RESEARCH AND DEVELOPMENT CO LTD. | ||
| Patents | 5,508,020; 5,585,007; 5,641,803; 5,703,017; 5,708,011; 6,054,430; 6,342,476; 6,362,161; 6,468,967; 6,483,009; 6,509,013; 6,852,689; 7,199,098; 7,511,014; 8,232,250; 8,367,605; 8,399,413; 8,552,025; 8,642,025; 8,969,302; 9,155,776; 9,533,022; 9,555,023 | ||
| Attorneys | Aaron M. Nelson; Alfred Henry Heckel; Alison Haddock Hutton; Anthony J. Fitzpatrick; Arun John Mohan; Beshoy Sharoupim; Brandon M. White; Brian J. Prew; Brian J. Robinson; Brian M. Kramer; Carolyn A. Alenci; Christopher P. Galligan; Christopher S. Kroon; Constance S. Huttner; Courtney M. Prochnow; Crystal R. Canterbury; Daniel P. Margolis; Daryl L. Wiesen; David A. Bilson; David J. Austin; David L. Anstaett; David M. Fry; David M. Hashmall; Deanne M. Mazzochi; Dominick T. Gattuso; E. Anthony Figg; Elizabeth J. Holland; Emily J. Greb; Erin M. Forbes; Eve H. Ormerod; Frederick L. Cottrell , III; Grant J. Esposito; Jennifer P. Nock; John C. Phillips , Jr.; John T. Bennett; John W. Shaw; Karen Elizabeth Keller; Marta Godecki; Matthew I. Kreeger; Matthew V. Anderson; Melanie K. Sharp; Nathan Roger Hoeschen; Neal C. Belgam; Nicholas K. Mitrokostas; Patrick C. Gallagher; Rachel Krevans; Rachel L. Pernic Waldron; Randy Elizabeth Brenner-Leifer; Richard D. Kirk; Richard L. Renck; Robert D. Swanson; Robert M. Vrana; Sara E. Bussiere; Selena E. Molina; Seth E. Cockrum; Shannon M. Bloodworth; Sharon L. Davis; Stephen B. Brauerman; Thomas H. Ehrich; Vanessa Ribeiro Tiradentes; Vincent L. Capuano; William A. Rakoczy; William G. James | ||
| Firms | Bayard, P.A.; Duane Morris, LLP; Gould & Ratner LLP; Heyman Enerio Gattuso & Hirzel LLP; Law Office of Michael R. Abram; Phillips, Goldman, McLaughlin & Hall, P.A.; Richards, Layton & Finger, PA; Selena E. Molina; Shaw Keller LLP; Smith, Katzenstein, & Jenkins LLP; Young, Conaway, Stargatt & Taylor LLP | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Teva Pharmaceuticals USA Inc. v. Sandoz Inc.
The small molecule drugs covered by the patents cited in this case are Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , and Start Trial .
Biologic Drugs cited in Teva Pharmaceuticals USA Inc. v. Sandoz Inc.
The biologic drugs covered by the patents cited in this case are Start Trial , Start Trial , and Start Trial .
Details for Teva Pharmaceuticals USA Inc. v. Sandoz Inc. (D. Del. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | 1 | Complaint | entN o. 8 ,232,250 (“t h e’250pa t ent …2014 31 January 2017 1:14-cv-01171 830 Patent Defendant District Court, D. | External link to document |
| 0000-00-00 | 114 | Stipulation | invalidity of U.S. Patent Nos. 8,232,250 (“the ’250 patent”), 8,399,413 (“the ’413 patent”), and 8,969,302…8,969,302 (“the ’302 patent) (collectively, the “patents-in-suit”), which, like the ’776 patent, are …’776 patent shares a common inventor and specification with the patents-in-suit and each patent is generally… Court: WHEREAS, U.S. Patent No. 9,155,776 (“the ’776 patent”) issued on October 13, 2015 and…that the patents involve similar subject matter, amending the pleadings to include the ’776 patent would | External link to document |
| 0000-00-00 | 116 | Patent/Trademark Report to Commissioner | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,232,250; 8,399,413; 8,969,302…2014 31 January 2017 1:14-cv-01171 830 Patent Defendant District Court, D. | External link to document |
| 0000-00-00 | 127 | Notice of Service | Defendants' Proposed Claim Constructions for U.S. Patent No. 9,155,776 filed by Mylan Inc., Mylan Pharmaceuticals…2014 31 January 2017 1:14-cv-01171 830 Patent Defendant District Court, D. | External link to document |
| 0000-00-00 | 130 | Notice of Service | Joint Invalidity Contentions Regarding U.S. Patent No. 9,155,776 B2 filed by Momenta Pharmaceuticals Inc.…2014 31 January 2017 1:14-cv-01171 830 Patent Defendant District Court, D. | External link to document |
| 0000-00-00 | 139 | Claim Construction Opening Brief | CONSTRUCTION OPENING BRIEF Regarding U.S. Patent No. 9,155,776 filed by Momenta Pharmaceuticals Inc., Sandoz…2014 31 January 2017 1:14-cv-01171 830 Patent Defendant District Court, D. | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
